搜尋結果
Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of ...
CNBC· 7 小時前Eli Lilly on Friday said it applied for U.S. approval of its weight loss drug Zepbound for the ...
Bloomberg Daybreak Europe: France's Finance Hub At Risk - Bloomberg
Bloomberg· 20 小時前Overnight on Wall Street is morning in Europe.Monitor your investments 24 hours a day, around the clock from around the ...
Council Post: Five Steps To Decoding AI-Powered Impersonation Attacks
Forbes· 22 小時前Stu Sjouwerman is the founder and CEO of KnowBe4 Inc., a security awareness training and simulated phishing platform. AI ...